Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and ...
Citi initiated coverage of Cytokinetics (CYTK) with a Buy rating and $86 price target. The shares seem attractive at current levels, given the ...
The 30-second spot for Brown University Health, formerly Lifespan, will air regionally, and everyone in it is an actual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback